Laser 1, AMD 0
Friday, February 13 2015 | 00 h 00 min | Vision Science
A new laser treatment administered during early stages of age-related macular degeneration may slow, even reverse, the progression of the disease.
The new technique involving nanosecond laser may also have implications for other eye diseases such as diabetic macular oedema, diabetic retinopathy and retinopathy of prematurity.
A study conducted on humans and mice showed that treatment using low-energy nanosecond laser limits the progression of the disease, without damaging the retina. Furthermore, treatment in one eye can also produce positive effects in the other untreated eye.
Gerald Weissmann, editor-in-chief of The FASEB Journal, which published the findings, believes that this research could “usher in an era in which age-related macular degeneration is either eliminated or no longer considered a serious disease.”
For further information: http://www.sciencedaily.com/releases/2015/02/150202105602.htm
